Stock Screener App

Frei -

Installieren

14.95

4.18% 0.60

after-market

Handel nachbörslich: 14.95

Cullinan Therapeutics Inc (CGEM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	0.60% 55.26	55.59	75.80	55.00	48.85
Operating Income/Loss	0.60% -55.26	-55.59	-75.80	-55.00	-48.85
Income/Loss From Continuing Operations Before Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Income/Loss From Continuing Operations After Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Net Income/Loss	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$54.26

2.69%

RPRX

$48.70

0.25%

BNTX

$99.47

1.08%

RVMD

$152.54

3.76%

INSM

$146.74

4.34%

ONC

$319.94

3.21%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters